Research
-
A New Model for Pricing Drugs of Uncertain Efficacy
Goldman, Van Nuys and colleagues propose a three-part pricing (TPP) model that ties prices to value but removes the need to monitor efficacy in each patient. The model creates a tiered system, with prices varying over fixed time intervals.
Categorized in -
Medicare Graduate Medical Education Funding is Not Addressing the Primary Care Shortage: We Need a Radically Different Approach
Schaeffer Initiative experts evaluate the impact of Medicare funding for hospitals, physicians and medical education on specialty selection by new doctors.
-
State Individual Mandates: Hows and Whys
State mandates are a straightforward way to avert the negative consequence of federal mandate repeal at the state level, according to the latest analysis out of the USC-Brookings Schaeffer Initiative.
-
The Standardized Pressure Injury Prevention Protocol (SPIPP) for Improving Nursing Compliance with Best Practice Guidelines
The SPIPP checklist of quality improvement interventions is well positioned to have an immediate impact on hospital-acquired pressure injuries prevention in hospitals globally.
Categorized in -
Racial and Ethnic Differences in Trends in Dementia Prevalence and Risk Factors in the United States
The researchers find disparities in dementia prevalence declined between blacks and whites and increased between Hispanics and whites.
-
Inpatient Medicaid Usage and Expenditure Patterns After Changes in Supplemental Nutrition Assistance Program Benefit Levels
Changes in SNAP benefit levels were associated with changes in inpatient Medicaid usage and cost patterns.
Categorized in -
Generic Drug Price Hikes And Out-Of-Pocket Spending For Medicare Beneficiaries
The share of generic drugs that at least doubled in price increased fourfold according to the Health Affairs study. But, this share is still a small percentage of the generic market.
Categorized in -
Mortality Risk, Insurance, and the Value of Life
In a working paper submitted to the National Bureau of Economic Research, Darius Lakdawalla found mortality improvement may be worth more, not less, to patients facing shorter lives.
Categorized in -
The California Competitive Model: How Has it Fared, and What’s Next?
The combined effect of policies and consolidation trends was a substantial reduction in the competitiveness of provider markets in California, which reduced health plans’ ability to leverage competitive provider markets and negotiate lower prices and other benefits for their members.
Categorized in -
Multidimensional Comparison of Countries’ Adaptation to Societal Aging
Overall, Norway and Sweden rank first in adaptation to aging, followed by the U.S., The Netherlands, and Japan. Central and eastern European countries rank at the bottom, with untapped potential for successful aging.
Categorized in